Limagrain adopte la technologie I-SceI de Cellectis pour des utilisations commerciales dans les plantes
Limagrain takes a commercial license to Cellectis’ I-SceI meganuclease technology for use in plants

March 09

Full-year results for 2008 in line with Cellectis’ development strategy
Résultats 2008 en phase avec la stratégie de développement de Cellectis

November 07

Cellectis launches new program with Bayer Cropscience for uses of meganuclease technology in crops

June 07

Cellectis S.A. wins a patent battle in the field of targeted recombination and gene correction - The European Patent Office confirms revocation of Sangamo's patent

May 07

Cellectis reaches key milestone in collaboration with Bayer CropScience on uses of meganuclease technology in plants

June 06

Cellectis and Bayer CropScience enter into a collaboration to use meganuclease technology in plants

January 06

Cellectis and BASF Plant Science sign a license under the Meganuclease technology for marker genes excision in crops

June 05

Cellectis S.A. wins patent battle in the field of targeted recombination and gene correction: European Patent Office affirms revocation of Sangamo Biosciences' licensed patent

February 04

Cellectis SA extends its technology agreement with BASF Plant Science GmbH for marker genes excision in crops

January 04

Cellectis and Diversa enter into a License Agreement for microorganisms improvement

May 03

Cellectis SA and BASF Plant Science GmbH enter into technology agreement

April 03

Cellectis and Limagrain Group announce an agreement

March 03

Pioneer to assess Cellectis technology for use in trait development
 

www.cellectis.com